At a moment when medication therapy for sickle cell disease (SCD) leaves too many behind and widespread access to curative gene therapies still lies in the distant future, automated red blood cell exchange is experiencing renewed interest. To improve patients’ lives, a broad commitment is needed to expand access to transfusion therapies. The post Beyond…
Kennedy emphasized that these inefficiencies aren’t just administrative headaches, they’re costing lives. Nowhere is this more evident than in organ-transplant logistics: the way organs get assigned – and move – from donors to patient recipients. The post RFK’s Hearing: Inefficiencies in Government-Controlled Systems appeared first on MedCity News.
Bain Capital’s buyout of Mitsubishi Tanabe Pharma brings a company with a drug portfolio and pipeline in areas such as immunology, central nervous system disorders, and metabolic disease. This business is the pharmaceuticals division of Japanese conglomerate Mitsubishi Chemical Group. The post Bain Capital Broadens Its Biotech Reach With $3.3B Deal for Mitsubishi Tanabe Pharma…
Fay’s $50 million Series B round was led by Goldman Sachs. In total, the company has raised $75 million. The post Fay Raises $50M to Expand Access to Nutrition Counseling Services appeared first on MedCity News.
It’s time to replace this system with one that works for patients and invites disruption. We need to put control back in the hands of patients, allowing them to own their health records, make independent decisions, and switch to fair and transparent alternatives. The post The End of Corporate-Controlled Care? AI and Patient Access Fuel…
The evolving landscape of healthcare demands that health plans continuously refine their engagement strategies, making this decision more critical than ever. Plan leaders must consider key factors, including cost, speed, scalability, and effectiveness, to guide them toward the most impactful approach. The post Navigating the Build vs. Buy Debate for Member Engagement Solutions appeared first…
[Sponsored] A Data-Driven Guide to Patient Access Success highlights how focusing on data accuracy and relevance can enhance healthcare practice performance. The post A Guide to Boosting Healthcare Practice Performance appeared first on MedCity News.
Teladoc Health’s acquisition of Catapult Health will add “another channel” to funnel patients into Teladoc’s chronic care programs, according to one healthcare expert. The post Why Teladoc Health is Acquiring Catapult Health for $65M appeared first on MedCity News.
Currently available therapies for Hunter syndrome don’t cross the blood-brain barrier to address cognitive symptoms of the inherited enzyme deficiency. Denali Therapeutics’ technology gets its drug across the protective membrane, and the biotech plans to seek accelerated FDA approval in this rare disease. The post Denali’s Data in Rare Enzyme Deficiency Keep It on Pace…
If the guidelines for data sharing are not adhered to by providers, then all the work that has gone into revising this regulation will have been for nothing. But the road to compliance doesn’t have to be overwhelming. Here are three essential steps for healthcare leaders in navigating the soon-to-be Part 2 landscape. The post…